LEADER 00000cam 22007097i 4500
001 on1375084527
003 OCoLC
005 20240103213016.0
006 m o d
007 cr un|---aucuu
008 230406s2023 sz a ob 100 0 eng d
019 1374815509|a1379506341|a1380479676|a1385501182|a1389623983
|a1396916934
020 9783031231759|q(electronic bk.)
020 3031231759|q(electronic bk.)
020 |z9783031231742|q(print)
020 |z3031231740
024 7 10.1007/978-3-031-23175-9|2doi
035 (OCoLC)1375084527|z(OCoLC)1374815509|z(OCoLC)1379506341
|z(OCoLC)1380479676|z(OCoLC)1385501182|z(OCoLC)1389623983
|z(OCoLC)1396916934
040 GW5XE|beng|erda|epn|cGW5XE|dYDX|dEBLCP|dOCLCF|dYDX|dOCLCO
|dWSU|dOCLCO|dOCLCL
049 STJJ
050 4 RC280.H4|bT74 2021
072 7 MJCL|2bicssc
072 7 MED062000|2bisacsh
072 7 MJCL|2thema
082 04 616.99/491|223/eng/20230406
111 2 Trends in Head and Neck Oncology (Conference)|n(8th :
|d2021 :|cAmsterdam, Netherlands)
245 10 Critical issues in head and neck oncology :|bkey concepts
from the Eighth THNO Meeting /|cJan B. Vermorken, Volker
Budach, C. René Leemans, Jean-Pascal Machiels, Piero
Nicolai, Brian O'Sullivan, editors.
246 3 THNO Meeting
264 1 Cham :|bSpringer,|c2023.
300 1 online resource (ix, 365 pages) :|billustrations (some
color)
336 text|btxt|2rdacontent
337 computer|bc|2rdamedia
338 online resource|bcr|2rdacarrier
504 Includes bibliographical references.
505 0 The gut microbiota and anticancer immunotherapy, Laurence
Zitvogel -- The bidirectional communication between tumor
cells and other components of the tumor microenvironment,
Phil Sloan -- Resistance mechanisms in immune checkpoint
inhibitors and radiotherapy and how to overcome this,
Kirsten Lauber -- DNA repair mechanisms as a new target in
head and neck cancer, Kevin Harrington -- How to
standardize molecular profiling programs for routine
patient care, Ingeborg Tinhofer -- Novel immune oncology
targets beyond PD-1/PD-L1 in head and neck cancer,
Christophe Le Tourneau -- Analytic methods to understand
head and neck cancer evolution to guide therapeutic
approaches, Ben O'Leary -- Clinical cases, Jean Pascal
Machiels -- Updates from the European Head & Neck Society
(EHNS), Wojciech Golusinski (President of EHNS) Section 2:
Primary disease Piero Nicolai -- Sensitivity and
specificity of extranodal extension in SCCHN: unlocking
the strongest prognostic factor in head and neck cancer,
Brian O'Sullivan -- From photon to proton: what's in it
for head and neck cancer patients?, Volker Budach --
Lessons learned from RTOG 1016 and DE-ESCALaTE: what's
next?, Hisham Mehanna.-Treatment intensification in LA-
SCCHN: what are the options and for who?, Jan Vermorken --
Immune checkpoint inhibitors in the curative setting:
preclinical and clinical data, Jean-Pascal Machiels --
Carcinoma of unknown primary: diagnostics and the
potential of transoral surgery, René Leemans -- Clinical
cases, Volker Budach -- Individualized therapy in 1-line R
/M-SCCHN: what selection criteria should we use?, Petr
Szturz -- Patterns of response to immune oncology drugs:
how relevant are they in SCCHN?, Amanda Psyrri -- The role
of radiotherapy in oligometastatic or oligoprogressive
disease in R/M-SCCHN, Daan Nevens -- Updates from the
EORTC Head and Neck Cancer Group (HNCG), Jean-Pascal
Machiels (Chair of EORTC-HNCG) -- Real world evidence in
head and neck cancer, Anil D'Cruz (UICC president --
Pathology driven treatment of skull base tumors, Piero
Nicolai -- Modern day reconstruction of facial bones, Sat
Parmar -- Targeting molecular/minimal residual disease
using novel technologies and clinical trials design,
Lillian Siu -- New developments in surgery for malignant
salivary gland tumors, Jeroen Meulemans -- New systemic
therapies in salivary gland cancer, Ethan Argiris.
Exercise and nutrition interventions in head and neck
cancer, Paolo Bossi -- Telehealth intervention in head and
neck cancer patients: a promise?, Irma Verdonck-de Leeuw.
506 0 Open access.|5GW5XE
520 This is an open access book. With a wealth of exciting
data emerging in this rapidly evolving field this book
will review the state-of-the-art knowledge with emphasis
on multidisciplinary decision and management of head and
neck cancer. The book provides significant detail on a
wide range of topics including: the role of new targets
for treatment, immunotherapy, resistance mechanisms,
standardizing molecular profiling programs, and new
methods to guide therapeutic approaches. In addition
different disease situations are addressed including
different treatment approaches in primary disease and in
recurrent and/or metastatic disease as well as new
developments in pathology, surgery and reconstruction
techniques, new systemic therapies in salivary gland
cancer, and supportive care and follow-up. All disciplines
involved in the treatment of head & neck cancer are
covered with a focus on translation into daily practice.
The 8th-THNO is designed for medical oncologists, head and
neck surgeons, radiation oncologists, otolaryngologists,
and other medical professionals involved in the treatment
of patients with head and neck cancer.
588 0 Online resource; title from PDF title page (SpringerLink,
viewed April 6, 2023).
590 Springer Nature|bSpringer Nature - SpringerLink eBooks -
Fully Open Access
650 0 Head|xCancer|vCongresses.
650 0 Neck|xCancer|vCongresses.
650 7 Head|xCancer|2fast
650 7 Neck|xCancer|2fast
655 0 Electronic books.
655 2 Congress
655 7 proceedings (reports)|2aat
655 7 Conference papers and proceedings|2fast
655 7 Conference papers and proceedings.|2lcgft
700 1 Vermorken, Jan B.,|eeditor.
700 1 Budach, Volker,|eeditor.
700 1 Leemans, C. René,|eeditor.
700 1 Machiels, Jean-Pascal,|eeditor.
700 1 Nicolai, P.|q(Piero),|d1954-|eeditor.|1https://id.oclc.org
/worldcat/entity/E39PBJtGVTFDtRFDYYC46cQ6rq
700 1 O'Sullivan, Brian,|d1952-|eeditor.|1https://id.oclc.org/
worldcat/entity/E39PBJht99r7mdVxVfbBBcHt8C
776 08 |cOriginal|z3031231740|z9783031231742|w(OCoLC)1351560296
914 on1375084527
994 92|bSTJ
